IBRX Reports Record Q2 Revenue Up 92%
IBRX Q2 revenue rises 92% year-over-year
Story updates
11:34:17 AM UTC
SquawkNews
IBRX - ImmunityBio Reports Record Q2 2026 Net Product Revenue of $50.7 Million, Up 92% Year-Over-Year; First-Half Revenue Up 121% to $94.8 Million
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.